Ceribell CBLL
NASDAQ CBLL
$27.14 -0.54 (-1.95%)
At close: Oct 21, 2026 · 4:00 PM EDT

Ceribell (CBLL) Return on Equity [ROE] (2024 - 2026)

Updated

Ceribell (CBLL) reported Return on Equity [ROE] of -49.05% for Q2 2026, down 21.05 percentage points from -27.99% a year earlier and down 8.27 percentage points from the prior quarter.

Analysis

Ceribell (CBLL) Return on Equity [ROE] (2024 - 2026) Analysis & Trends

For FY2025, Ceribell posted Return on Equity [ROE] of -30.83%, up 71.70 percentage points from FY2024.

  • By year, Return on Equity [ROE] came in at -102.53% in FY2024.
  • The Q2 2026 figure ranks as the lowest quarterly Return on Equity [ROE] since Q4 2024.
  • Per Business Quant data, the three quarters before Q2 2026 came in at -40.77% (Q1 2026), -33.44% (Q4 2025) and -31.20% (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROE (Qtr)
1 Thermo Fisher Scientific 257.99 Bn 237.02 Bn 4.88 Bn 13.36%
2 Abbott Laboratories 175.01 Bn 145.44 Bn 7.27 Bn 10.39%
3 Danaher 164.93 Bn 148.74 Bn 3.61 Bn 7.56%
4 Intuitive Surgical 151.84 Bn 131.26 Bn 1.96 Bn 17.60%
5 Medtronic 119.05 Bn 84.30 Bn 6.34 Bn 10.44%
6 Stryker 113.89 Bn 100.00 Bn 4.50 Bn -3.90%
7 Boston Scientific 65.37 Bn 60.13 Bn 3.85 Bn 14.31%
8 Becton Dickinson 53.36 Bn 50.51 Bn 2.32 Bn 3.88%
9 Edwards Lifesciences 50.83 Bn 34.83 Bn 1.35 Bn 9.53%
10 Ceribell 1.03 Bn 432.80 Mn 25.94 Mn -49.05%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -49.05%
Mar 31, 2026 -40.77%
Dec 31, 2025 -33.44%
Sep 30, 2025 -31.20%
Jun 30, 2025 -27.99%
Mar 31, 2025 -24.04%
Dec 31, 2024 -146.62%
API Access

Ceribell Return on Equity [ROE] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=CBLL&period=max&api_key=YOUR_API_KEY